BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

825 related articles for article (PubMed ID: 29288528)

  • 1. Overexpression of miR-22 attenuates oxidative stress injury in diabetic cardiomyopathy via Sirt 1.
    Tang Q; Len Q; Liu Z; Wang W
    Cardiovasc Ther; 2018 Apr; 36(2):. PubMed ID: 29288528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice.
    Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X
    Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antioxidant edaravone prevents cardiac dysfunction by suppressing oxidative stress in type 1 diabetic rats and in high-glucose-induced injured H9c2 cardiomyoblasts.
    Ji L; Liu Y; Zhang Y; Chang W; Gong J; Wei S; Li X; Qin L
    Can J Physiol Pharmacol; 2016 Sep; 94(9):996-1006. PubMed ID: 27376621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Noncoding RNA OIP5-AS1 Overexpression Promotes Viability and Inhibits High Glucose-Induced Oxidative Stress of Cardiomyocytes by Targeting MicroRNA-34a/SIRT1 Axis in Diabetic Cardiomyopathy.
    Sun H; Wang C; Zhou Y; Cheng X
    Endocr Metab Immune Disord Drug Targets; 2021; 21(11):2017-2027. PubMed ID: 33380310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetylcysteine attenuates myocardial dysfunction and postischemic injury by restoring caveolin-3/eNOS signaling in diabetic rats.
    Su W; Zhang Y; Zhang Q; Xu J; Zhan L; Zhu Q; Lian Q; Liu H; Xia ZY; Xia Z; Lei S
    Cardiovasc Diabetol; 2016 Oct; 15(1):146. PubMed ID: 27733157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA HOTAIR functions as a competing endogenous RNA to upregulate SIRT1 by sponging miR-34a in diabetic cardiomyopathy.
    Gao L; Wang X; Guo S; Xiao L; Liang C; Wang Z; Li Y; Liu Y; Yao R; Liu Y; Zhang Y
    J Cell Physiol; 2019 Apr; 234(4):4944-4958. PubMed ID: 30216438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LAZ3 protects cardiac remodeling in diabetic cardiomyopathy via regulating miR-21/PPARa signaling.
    Gao L; Liu Y; Guo S; Xiao L; Wu L; Wang Z; Liang C; Yao R; Zhang Y
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3322-3338. PubMed ID: 30031228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-30c/PGC-1β protects against diabetic cardiomyopathy via PPARα.
    Yin Z; Zhao Y; He M; Li H; Fan J; Nie X; Yan M; Chen C; Wang DW
    Cardiovasc Diabetol; 2019 Jan; 18(1):7. PubMed ID: 30635067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-Regulation of MicroRNA-137 Improves High Glucose-Induced Oxidative Stress Injury in Human Umbilical Vein Endothelial Cells by Up-Regulation of AMPKα1.
    Li J; Li J; Wei T; Li J
    Cell Physiol Biochem; 2016; 39(3):847-59. PubMed ID: 27497953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of prolyl hydroxylase 3 ameliorates cardiac dysfunction in diabetic cardiomyopathy.
    Xia Y; Gong L; Liu H; Luo B; Li B; Li R; Li B; Lv M; Pan J; An F
    Mol Cell Endocrinol; 2015 Mar; 403():21-9. PubMed ID: 25595486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosis.
    Sun X; Chen RC; Yang ZH; Sun GB; Wang M; Ma XJ; Yang LJ; Sun XB
    Food Chem Toxicol; 2014 Jan; 63():221-32. PubMed ID: 24269735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic overexpression of miR-92a-2-5p ameliorated cardiomyocyte oxidative stress injury in the development of diabetic cardiomyopathy.
    Yu M; Sun Y; Shan X; Yang F; Chu G; Chen Q; Han L; Guo Z; Wang G
    Cell Mol Biol Lett; 2022 Oct; 27(1):85. PubMed ID: 36209049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginsenoside Rg1 ameliorates diabetic cardiomyopathy by inhibiting endoplasmic reticulum stress-induced apoptosis in a streptozotocin-induced diabetes rat model.
    Yu H; Zhen J; Yang Y; Gu J; Wu S; Liu Q
    J Cell Mol Med; 2016 Apr; 20(4):623-31. PubMed ID: 26869403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating interleukin-1β promotes endoplasmic reticulum stress-induced myocytes apoptosis in diabetic cardiomyopathy via interleukin-1 receptor-associated kinase-2.
    Liu Z; Zhao N; Zhu H; Zhu S; Pan S; Xu J; Zhang X; Zhang Y; Wang J
    Cardiovasc Diabetol; 2015 Sep; 14():125. PubMed ID: 26394923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of miR-195 reduces diabetic cardiomyopathy in C57BL/6 mice.
    Zheng D; Ma J; Yu Y; Li M; Ni R; Wang G; Chen R; Li J; Fan GC; Lacefield JC; Peng T
    Diabetologia; 2015 Aug; 58(8):1949-58. PubMed ID: 25994075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
    Zhang J; Cheng Y; Gu J; Wang S; Zhou S; Wang Y; Tan Y; Feng W; Fu Y; Mellen N; Cheng R; Ma J; Zhang C; Li Z; Cai L
    Clin Sci (Lond); 2016 Apr; 130(8):625-41. PubMed ID: 26795437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress.
    You S; Qian J; Sun C; Zhang H; Ye S; Chen T; Xu Z; Wang J; Huang W; Liang G
    J Cell Mol Med; 2018 Mar; 22(3):1931-1943. PubMed ID: 29327811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-chain noncoding RNA-GAS5/hsa-miR-138-5p attenuates high glucose-induced cardiomyocyte damage by targeting CYP11B2.
    Zhuo X; Bai K; Wang Y; Liu P; Xi W; She J; Liu J
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 33682891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis of cardiomyocytes in diabetic cardiomyopathy involves overexpression of glycogen synthase kinase-3β.
    Wu W; Liu X; Han L
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30237226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protective effects of endogenous hydrogen sulfide modulator, S-propargyl-cysteine, on high glucose-induced apoptosis in cardiomyocytes: A novel mechanism mediated by the activation of Nrf2.
    Yang H; Mao Y; Tan B; Luo S; Zhu Y
    Eur J Pharmacol; 2015 Aug; 761():135-43. PubMed ID: 25979858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.